You just read:

ISTA Pharmaceuticals Reports Positive Preliminary Results from its Phase 1/2 Clinical Study of Bepotastine Besilate Nasal Spray for the Treatment of Symptoms Associated with Seasonal Allergic Rhinitis

News provided by

ISTA Pharmaceuticals, Inc.

Oct 06, 2010, 07:30 ET